Spots Global Cancer Trial Database for Afatinib Expanded Access Program
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Afatinib Expanded Access Program
Official Title: LUX-Lung EAP US; An Open Label Expanded Access Program of Afatinib (BIBW 2992) for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
Study ID: NCT01649284
Conditions
Interventions
Study Description
Brief Summary: This is an open-label, multi-center, single-arm trial, designed to provide early access to afatinib and to provide additional information on the safety and efficacy of afatinib in advanced NSCLC patients who harbor an EGFR mutation.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
1200.45.004 Boehringer Ingelheim Investigational Site, Mobile, Alabama, United States
1200.45.116 Boehringer Ingelheim Investigational Site, Goodyear, Arizona, United States
1200.45.057 Boehringer Ingelheim Investigational Site, Hot Springs, Arkansas, United States
1200.45.078 Boehringer Ingelheim Investigational Site, Anaheim, California, United States
1200.45.114 Boehringer Ingelheim Investigational Site, Burbank, California, United States
1200.45.123 Boehringer Ingelheim Investigational Site, Glendale, California, United States
1200.45.115 Boehringer Ingelheim Investigational Site, Lakewood, California, United States
1200.45.117 Boehringer Ingelheim Investigational Site, Long Beach, California, United States
1200.45.102 Boehringer Ingelheim Investigational Site, Monterey, California, United States
1200.45.091 Boehringer Ingelheim Investigational Site, Pleasant Hill, California, United States
1200.45.098 Boehringer Ingelheim Investigational Site, Pleasant Hill, California, United States
1200.45.006 Boehringer Ingelheim Investigational Site, Ranco Cucamonga, California, United States
1200.45.003 Boehringer Ingelheim Investigational Site, Southington, Connecticut, United States
1200.45.007 Boehringer Ingelheim Investigational Site, Stamford, Connecticut, United States
1200.45.026 Boehringer Ingelheim Investigational Site, Hollywood, Florida, United States
1200.45.097 Boehringer Ingelheim Investigational Site, Hollywood, Florida, United States
1200.45.017 Boehringer Ingelheim Investigational Site, Jacksonville, Florida, United States
1200.45.058 Boehringer Ingelheim Investigational Site, Jacksonville, Florida, United States
1200.45.016 Boehringer Ingelheim Investigational Site, Lakeland, Florida, United States
1200.45.103 Boehringer Ingelheim Investigational Site, Miami Beach, Florida, United States
1200.45.037 Boehringer Ingelheim Investigational Site, Orlando, Florida, United States
1200.45.056 Boehringer Ingelheim Investigational Site, Port St. Lucie, Florida, United States
1200.45.119 Boehringer Ingelheim Investigational Site, Titusville, Florida, United States
1200.45.095 Boehringer Ingelheim Investigational Site, Alpharetta, Georgia, United States
1200.45.029 Boehringer Ingelheim Investigational Site, Athens, Georgia, United States
1200.45.042 Boehringer Ingelheim Investigational Site, Macon, Georgia, United States
1200.45.121 Boehringer Ingelheim Investigational Site, Valdosta, Georgia, United States
1200.45.024 Boehringer Ingelheim Investigational Site, Decatur, Illinois, United States
1200.45.009 Boehringer Ingelheim Investigational Site, Evanston, Illinois, United States
1200.45.099 Boehringer Ingelheim Investigational Site, Peoria, Illinois, United States
1200.45.040 Boehringer Ingelheim Investigational Site, Waterloo, Iowa, United States
1200.45.041 Boehringer Ingelheim Investigational Site, Wichita, Kansas, United States
1200.45.083 Boehringer Ingelheim Investigational Site, Marrero, Louisiana, United States
1200.45.087 Boehringer Ingelheim Investigational Site, Metairie, Louisiana, United States
1200.45.019 Boehringer Ingelheim Investigational Site, Columbia, Maryland, United States
1200.45.039 Boehringer Ingelheim Investigational Site, Rockville, Maryland, United States
1200.45.053 Boehringer Ingelheim Investigational Site, Ann Arbor, Michigan, United States
1200.45.046 Boehringer Ingelheim Investigational Site, Detroit, Michigan, United States
1200.45.100 Boehringer Ingelheim Investigational Site, Jackson, Mississippi, United States
1200.45.067 Boehringer Ingelheim Investigational Site, St. Louis, Missouri, United States
1200.45.071 Boehringer Ingelheim Investigational Site, Billings, Montana, United States
1200.45.021 Boehringer Ingelheim Investigational Site, Omaha, Nebraska, United States
1200.45.066 Boehringer Ingelheim Investigational Site, Freehold, New Jersey, United States
1200.45.105 Boehringer Ingelheim Investigational Site, Albuquerque, New Mexico, United States
1200.45.080 Boehringer Ingelheim Investigational Site, Brooklyn, New York, United States
1200.45.068 Boehringer Ingelheim Investigational Site, Fresh Meadows, New York, United States
1200.45.051 Boehringer Ingelheim Investigational Site, New York, New York, United States
1200.45.092 Boehringer Ingelheim Investigational Site, New York, New York, United States
1200.45.001 Boehringer Ingelheim Investigational Site, Charlotte, North Carolina, United States
1200.45.086 Boehringer Ingelheim Investigational Site, Bismarck, North Dakota, United States
1200.45.048 Boehringer Ingelheim Investigational Site, Minot, North Dakota, United States
1200.45.090 Boehringer Ingelheim Investigational Site, Canton, Ohio, United States
1200.45.005 Boehringer Ingelheim Investigational Site, Columbus, Ohio, United States
1200.45.089 Boehringer Ingelheim Investigational Site, Tulsa, Oklahoma, United States
1200.45.094 Boehringer Ingelheim Investigational Site, Portland, Oregon, United States
1200.45.020 Boehringer Ingelheim Investigational Site, Hershey, Pennsylvania, United States
1200.45.096 Boehringer Ingelheim Investigational Site, Johnstown, Pennsylvania, United States
1200.45.060 Boehringer Ingelheim Investigational Site, Philadelphia, Pennsylvania, United States
1200.45.085 Boehringer Ingelheim Investigational Site, Pottstown, Pennsylvania, United States
1200.45.120 Boehringer Ingelheim Investigational Site, Rapid City, South Dakota, United States
1200.45.049 Boehringer Ingelheim Investigational Site, Cookeville, Tennessee, United States
1200.45.113 Boehringer Ingelheim Investigational Site, El Paso, Texas, United States
1200.45.045 Boehringer Ingelheim Investigational Site, Fairfax, Virginia, United States
1200.45.076 Boehringer Ingelheim Investigational Site, Seattle, Washington, United States
1200.45.093 Boehringer Ingelheim Investigational Site, Charleston, West Virginia, United States
1200.45.125 Boehringer Ingelheim Investigational Site, Wausau, Wisconsin, United States
Contact Details
Name: Boehringer Ingelheim
Affiliation: Boehringer Ingelheim
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
